Quantcast
Last updated on April 18, 2014 at 1:21 EDT

Latest Tuberculosis treatment Stories

2010-09-23 07:00:00

Discovery could help determine who will develop the disease and who won't DALLAS, Sept. 23 /PRNewswire-USNewswire/ -- Dallas scientists recently discovered a molecular signature in the blood of patients with tuberculosis (TB) that may explain why some people develop an active TB infection, while others exposed to the bacteria which causes the dangerous respiratory virus do not. Researchers at Baylor Institute for Immunology Research (BIIR) in Dallas, a component of Baylor Research...

2010-09-01 16:00:00

GENEVA, Sept. 1 /PRNewswire/ -- A study(1) published in The New England Journal of Medicine today reports that a new molecular tuberculosis (TB) test, Xpert® MTB/RIF, provides highly sensitive detection of tuberculosis and drug resistance in low resource settings more easily and in significantly less time than any current, widely used diagnostic. The study, conducted by the Foundation for Innovative New Diagnostics (FIND), showed that the Xpert® MTB/RIF...

2010-07-22 12:59:42

A clinical trial in Cambodia has found it possible to prolong the survival of untreated HIV-infected adults with very weak immune systems and newly diagnosed tuberculosis (TB) by starting anti-HIV therapy two weeks after beginning TB treatment, rather than waiting eight weeks, as has been standard. This finding by scientists co-funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, and the French National Agency for Research on...

2010-06-23 13:48:19

Press release from PLoS Medicine A large, systematic postmortem study carried out in South Africa by Ted Cohen and colleagues has revealed that 94% of deceased patients were HIV infected and 50% had culture-positive tuberculosis at the time of death. These data, which reveal that the toll of tuberculosis in young people (age 20-45) in KwaZulu-Natal is higher than we previously thought, are published this week in the open access medical journal PLoS Medicine. Every year, nearly 10 million...

2010-06-11 13:49:44

When applied to HIV care, the community-based model of directly observed therapy (DOT) has no effect on virologic outcomes, but significantly improves patient survival. This is according to researchers at the Johns Hopkins Bloomberg School of Public Health, in collaboration with colleagues at University of Cape Town, South Africa, who conducted the first randomized controlled trial of patient-nominated treatment-supporters providing partial DOT in resource-limited settings. The researchers...

3968655843ed38798b42f2404d7ffd291
2010-06-07 14:35:00

A study published in the American Journal of Public Health finds links between mining and the spread of tuberculosis in sub-Saharan Africa. The study analyzed data from 44 sub-Saharan African countries and found that the greater the mining production, the higher the country's incidence of TB. The research concluded that as many as one-third of new TB cases "” 750,000 cases annually "” may be attributable to mining. "We have long known that the conditions on the mines "” both...

2010-05-19 14:18:06

According to a paper published today in the Lancet, there is unprecedented progress in the development of the global tuberculosis (TB) drug pipeline with 10 drug candidates currently in clinical development. The paper was written by a team of renowned international experts led by Zhenkun Ma, Ph.D., Chief Scientific Officer for the TB Alliance, a not-for-profit organization accelerating the discovery and development of new TB drugs. The article, published as part of the Lancet's Series on...

2010-05-17 07:01:58

HIV-infected patients who are falsely diagnosed as having tuberculosis (TB) have higher rates of mortality than those who are correctly diagnosed with the disease, according to a study conducted by researchers at University of California-San Francisco and Makerere University-Kampala. "Among HIV-infected persons with suspected TB, falsely diagnosing persons with TB by rapid testing was associated with increased mortality when compared with the group of patients who received the correct...

2010-05-03 08:00:00

NEW YORK and BANGALORE, India, May 3 /PRNewswire/ -- The Global Alliance for TB Drug Development (TB Alliance) and AstraZeneca announced today at the 2010 BIO International Convention that they have entered into a research collaboration agreement to accelerate the discovery, development and clinical use of drugs against tuberculosis (TB), including drug resistant strains of the disease. One in five patients with TB are resistant to at least one of today's standard first-line TB drugs...

2010-04-06 14:00:00

HAYWARD, Calif. and SHANGHAI, April 6 /PRNewswire/ -- MicuRx Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the development of antibiotics to treat drug-resistant bacteria, and Cumencor Pharmaceuticals, Inc. today announced that the companies have entered a collaboration with Pfizer (NYSE: PFE) to discover novel therapeutic agents to treat multi-drug resistant tuberculosis (MDR-TB). Cumencor Pharmaceuticals is a China-based biotechnology company applying MicuRx's...